Buy Fanhdi 500IU Factor VIII

Fanhdi 500IU is a Factor VIII concentrate used to manage bleeding disorders like hemophilia A. This clotting factor replacement therapy supports blood clotting when natural levels are low. Store at ambient temperature and follow handling instructions carefully.

Strength

500IU

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Instituto Grifols S.A

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Fanhdi 500IU is used to treat and prevent bleeding episodes in patients with hemophilia A, a genetic disorder causing low Factor VIII levels. It helps control bleeding during surgeries or injuries by replacing the missing clotting factor. This medication is also used for routine prophylaxis to reduce bleeding frequency in affected individuals.

Side Effects

Fanhdi 500IU works by temporarily increasing Factor VIII levels in the blood, supporting normal clotting processes. Patients may experience improved bleeding control and reduced recovery time after injuries or procedures. The effects vary by individual and depend on the severity of the clotting disorder.

Precautions & Warnings

Keep Fanhdi 500IU in its original packaging until ready to use. Protect from light and avoid freezing. Check the product for particles or discoloration before administration. Always follow the preparation and injection instructions provided by your healthcare provider. Do not use if the seal is broken or the product appears damaged.

Avoid Interactions

Fanhdi 500IU may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Avoid mixing with other intravenous solutions unless directed by a healthcare professional. Inform your doctor about all medications and supplements you are taking to prevent potential interactions.

References

Frequently Asked Questions

Fanhdi 500IU is used to treat and prevent bleeding in patients with hemophilia A by replacing missing Factor VIII.

Store Fanhdi 500IU at ambient temperature, away from light and moisture. Do not freeze.

Consult a healthcare provider before using Fanhdi 500IU if pregnant or breastfeeding.

Common side effects may include headache, nausea, or injection site reactions. Report severe reactions to a doctor.

No, Fanhdi 500IU requires a prescription and should only be used under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.